Offer - Urjas Oil for just ₹ 1
Rasilez FC 150 Mg Tablet is a prescription medicine that is available as a Tablet. It is primarily used for the treatment of High BP.
The optimal dosage of Rasilez FC 150 Mg Tablet is largely dependent on the individual's body weight, medical history, gender and age. Dosage also depends on the route of administration and your chief complaint for which the drug is prescribed. For detailed information on this, read through the dosage section.
Apart from the aforementioned side effects, Rasilez FC 150 Mg Tablet can also lead to other problems, which have been listed below. Normally, these side effects of Rasilez FC 150 Mg Tablet are not long lasting and go away when the treatment is finished. Consult your doctor if these side effects become worse or stay for a longer duration.
In addition, Rasilez FC 150 Mg Tablet's effect is Severe during pregnancy and Severe for lactating mothers. Further, the section on Rasilez FC 150 Mg Tablet related warnings talks about Rasilez FC 150 Mg Tablet's effects on the liver, heart and kidney.
Rasilez FC 150 Mg Tablet can cause adverse effects in certain medical conditions. It is strongly recommended to avoid Rasilez FC 150 Mg Tablet in conditions like Angioedema, Hyperkalemia, Low Blood Pressure (Hypotension). Some other conditions that can be affected by Rasilez FC 150 Mg Tablet are listed in the contraindications section below.
Drug interactions for Rasilez FC 150 Mg Tablet have been reported in the medical literature. A complete list of these interactions is given below.
You should also be aware that Rasilez FC 150 Mg Tablet is not safe while driving, and is not addiction.
Rasilez FC 150 Mg Tablet is used to treat the following -
Main Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
| Age Group | Dosage |
| Adult |
|
| Geriatric |
|
| 13 - 18 years (Adolescent) |
|
Is the use of Rasilez FC 150 Mg Tablet safe for pregnant women?
Rasilez has many dangerous side effects in pregnant women. If you are pregnant, do not consume Rasilez without medical advice.
Is the use of Rasilez FC 150 Mg Tablet safe during breastfeeding?
Taking Rasilez may lead to serious side effects if you are breastfeeding. Rasilez should not be taken by breastfeeding women unless prescribed by the doctor.
What is the effect of Rasilez FC 150 Mg Tablet on the Kidneys?
Very few cases of side effects of Rasilez on kidney have been reported.
What is the effect of Rasilez FC 150 Mg Tablet on the Liver?
Rasilez may have mild side effects on the liver. Most people will never see any effect on the liver.
What is the effect of Rasilez FC 150 Mg Tablet on the Heart?
Rasilez has very mild side effects on the heart.
If you are suffering from any of the following diseases, you should not take Rasilez FC 150 Mg Tablet unless your doctor advises you to do so -
Is this Rasilez FC 150 Mg Tablet habit forming or addictive?
Rasilez FC 150 Mg Tablet is not addictive in nature.
Is it safe to drive or operate heavy machinery when consuming?
After taking Rasilez FC 150 Mg Tablet, you should not drive or work on any heavy machine, as Rasilez FC 150 Mg Tablet can make you drowsy.
Is it safe?
Yes, Rasilez FC 150 Mg Tablet is safe but you must consult your doctor before taking it.
Is it able to treat mental disorders?
No, Rasilez FC 150 Mg Tablet is not used to treat mental disorders.
Interaction between Food and Rasilez FC 150 Mg Tablet
Taking Rasilez FC 150 Mg Tablet with food is safe.
Interaction between Alcohol and Rasilez FC 150 Mg Tablet
No research has been done on this till date. Therefore, it is not known what the effect of taking Rasilez FC 150 Mg Tablet with alcohol will be.
This medicine data has been created by -
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Tekturna® (aliskiren)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 508
